Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	28.62	69.68	54.17
Graham Fair Price	-6.90	10.58	11.36
PEG	19.27	-2.05	1.72
Price/Book	15.43	2.46	2.13
Price/Cash Flow	134.99	110.14	46.87
Prices/Earnings	34.18	25.63	19.10
Price/Sales	20.45	6.72	5.58
Price/FCF	134.99	110.14	46.87
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-1.16	0.17	0.18
Operating Margin	-10.53	0.09	0.10
ROA	-17.33	0.01	0.02
ROE	0.03	0.02	-13.98
ROIC	0.02	0.02	-16.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.15	< 0.005	25341.24
Dividends QOQ	< 0.005	0.03	1847.12
EBIT QOQ	0.07	-0.14	107.96
EPS QOQ	0.11	-0.13	12.50
FCF QOQ	0.64	-0.51	-21.03
Revenue QOQ	-0.06	-0.04	41.88
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	57.54	63.17	9.79
Days Sales Outstanding (DSO)	22.55	22.82	1.16
Inventory Turnover	1.56	1.42	-8.92
Debt/Capitalization	0.30	0.33	9.74
Quick Ratio	0.77	0.97	26.87
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	14.34	14.39	0.38
Cash	1.80	2.76	53.48
Capex	-0.09	-0.11	-26.82
Free Cash Flow	0.65	0.32	-50.69
Revenue	5.48	5.27	-3.80
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.49	1.73	15.84
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.67	7.45	11.71
Naive Interpretation	Member

06 - Financial Health · Weak

Rating